David Stamler
Directeur Général chez ALTERITY THERAPEUTICS LIMITED
Postes actifs de David Stamler
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALTERITY THERAPEUTICS LIMITED | Directeur Général | 07/01/2021 | - |
Directeur Technique/Scientifique/R&D | 01/05/2017 | 07/01/2021 |
Historique de carrière de David Stamler
Anciens postes connus de David Stamler
Sociétés | Poste | Début | Fin |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
AUSPEX PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 01/01/2011 | 05/05/2015 |
XENOPORT, INC. | Directeur Technique/Scientifique/R&D | 01/07/2008 | 19/11/2010 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Directeur Technique/Scientifique/R&D | 01/01/2005 | 01/01/2008 |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Corporate Officer/Principal | 01/01/2003 | 01/01/2005 |
Fujisawa Healthcare, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2003 | 01/01/2005 |
Astellas Research Institute of America LLC | Corporate Officer/Principal | 01/01/2000 | 01/01/2003 |
ABBOTT LABORATORIES | Directeur Technique/Scientifique/R&D | 01/01/1993 | 01/01/1997 |
Formation de David Stamler
The University of Chicago | Undergraduate Degree |
Pritzker School of Medicine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Japon | 2 |
Australie | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 6 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 8 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ALTERITY THERAPEUTICS LIMITED | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Entreprise privées | 6 |
---|---|
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Health Technology |
Fujisawa Healthcare, Inc. | |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Astellas Research Institute of America LLC |
- Bourse
- Insiders
- David Stamler
- Expérience